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Article abstract—Objectives: To evaluate the neural correlates of attention and working memory deficits in patients with
HIV-1. Method: fMRI was used to evaluate brain activity in 11 patients with HIV and 11 age-, sex-, education-, and
handedness-matched seronegative subjects, while performing a battery of tasks that required different levels of attention
for working memory. Results: Patients with HIV showed greater brain activation (blood oxygenation level dependent
signal changes) in some regions compared with control subjects while performing the same tasks. For the simpler tasks,
patients with HIV showed greater activation in the parietal regions. However, with more difficult tasks, patients with HIV
showed greater activation additionally in the frontal lobes. Reaction times during these tasks were slower but accuracy
was similar in the patients with HIV compared with control subjects. Conclusion: Injury to the neural substrate caused by
HIV infection may necessitate greater attentional modulation of the neural circuits, hence a greater use of the brain
reserve; additional activation of the frontal lobes is required to perform the more complex tasks. The task-dependent
increased frontal activation in patients with HIV suggests that the neural correlate of attentional deficits may be
excessive attentional modulation as a result of frontostriatal brain injury.
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Cognitive abnormalities commonly occur in patients
with HIV infection.1 Among otherwise healthy HIV-
positive patients, cognitive deficits are thought to be
infrequent,2 but some investigators suggest that more
sensitive measures may be needed to detect the mild
cognitive decline during the asymptomatic stage.3 In
later stages of HIV disease, with CD4 counts less than
100 cells/L, approximately 20% of patients may de-
velop a more disabling dementia syndrome directly re-
lated to HIV infection4; this syndrome has been termed
HIV cognitive motor complex.5 Early diagnosis and
treatment of HIV dementia is especially important be-
cause patients with early stages of the dementia may
show reversal of their cognitive deficits and neuro-
chemistry abnormalities after treatment.6
Typical neuropsychological deficits in HIV pa-
tients include decreased sustained attention, mental
flexibility, general motor speed, and memory.7,8 In
particular, working memory may be affected in these
patients.9-12 However, the underlying neuroanatomic
substrate for these neuropsychological deficits is un-
known. A variety of functional neuroimaging tech-
niques, including PET,13 SPECT,14,15 and MRS,16-18
have been applied to evaluate physiologic changes in
the brains of patients with HIV. Such functional
neuroimaging studies found alterations in cerebral
blood flow and metabolism, and invariably evaluated
the brain function at rest.
In this study, fMRI, using the blood oxygenation
level dependent (BOLD) contrast, was obtained in
subjects performing tasks that required increasing
cognitive load of attention and working memory.
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This allows us to correlate neuroimaging information
with behavioral performance and, thus, to identify the
neuroanatomic substrate of specific cognitive impair-
ments. fMRI is an ideal technique to study cerebral
activation because it is noninvasive and nonradioac-
tive; therefore, it can be performed repeatedly. Our aim
in this preliminary study was to explore neurophysio-
logic correlates of deficits in attention and working
memory in patients with HIV by using fMRI. Ideally,
the extent of physiologic abnormalities showed by fMRI
will predict the degree to which cognitive performance
is reduced in these patients.
Methods. Patients. Eleven men seropositive for HIV-1
(mean age, 41  4.8 years; education, 14  2.1 years; 1
left-handed and 10 right-handed) and 11 healthy seroneg-
ative men matched for age, education, and handedness
(mean age, 38  4.8 years; education, 16.4  3.3 years; 1
left-handed and 10 right-handed) were scanned with fMRI
while performing a set of working memory tasks with
varying degrees of difficulty. All patients with HIV were
recruited from a Los Angeles County hospital, and all sero-
negative control subjects were recruited from the local
community by advertisements or were friends or relatives
of the patients. Before the study, each patient underwent a
screening neuropsychiatric evaluation, including evalua-
tion with the HIV dementia scale devised by Power,19 the
Karnofsky score,20 and the Memorial Sloan–Kettering sys-
tem for AIDS dementia staging.21 The screening evaluation
also included routine chemistry, thyroid panel, syphilis se-
rology, CD4 cell count, and plasma viral load. Patients
were enrolled only if they fulfilled the inclusion criteria:
HIV-1 seropositive status, history of CD4 cell count 500/
mL, negative urine toxicology screen, no other chronic
medical or psychiatric illnesses, and MRI without struc-
tural abnormalities. Patients were excluded if they had a
history of drug dependence, focal brain lesions, head
trauma with loss of consciousness for more than 30 min-
utes, seizure disorders, hypertension, diabetes, or history
of neurosyphilis. Control subjects additionally were sero-
negative and taking no medications. Before the study, each
patient signed a written consent form approved by the
Institutional Review Board at Harbor-UCLA Research and
Education Institute.
Activation paradigms. The stimulation paradigms
were modeled after tasks on the California Computerized
Assessment Package.22 A battery of five tasks was pre-
sented twice in the same order for each participant. The
first was a simple reaction task: a number was flashed for
500 milliseconds at random times, with fixation, 10 times
per 30 seconds. The task was to push a low resistance
button as soon as a number appeared on the screen. Dur-
ing the control periods of 30 seconds, only a fixation cross
was displayed. This task was followed by four working
memory tasks. For the two sequential letter tasks, random
alphabetical letters were presented sequentially at a rate
of 1 per second (figure 1). The subjects were instructed to
push a button as quickly as possible when the current
letter was the same as the one before (one-back task) or
two before (two-back task). For the two sequential number
tasks, single digit numbers were sequentially displayed
instead (see figure 1). The participants were instructed to
respond when the number was one or two higher (one-
increment or two-increment tasks) than the previous num-
ber. During each task period of 30 seconds, five targets
were presented at random times. During the rest period
(30 seconds), nonsense characters of the same size were
randomly displayed at the same rate and luminance, and
the participants were instructed not to respond but to
maintain fixation at the center cross.
Each task was performed during two scans; each scan
consisted of four stimulation and four resting intervals.
Participant motion was minimized using extensive cush-
ioning and a bite-bar. The reaction times and accuracy
were recorded during the scans for all the tasks, except for
the two-back tasks because of a technical error. Visual
stimuli were generated on a Hewlett Packard workstation
(Palo Alto, CA) and displayed on a 20-inch monitor that
was visible through a mirror mounted on the head coil
inside the scanner. The monitor was placed at the end of
the patient table and magnetically shielded to avoid geo-
metric or chromatic distortions caused by the magnetic
field.
Functional MRI scans. Scans were performed on a
1.5-T system (SIGNA 5.7; General Electric, Milwaukee,
WI) with fast gradients (SR 120), using a quadrature head
coil. After obtaining an anatomic scan (fast inversion re-
covery, repetition time, 4500 milliseconds; echo time, 32
milliseconds; inversion time, 120 milliseconds; 36 slices,
resolution 0.9 	0.9 	 3.5 mm), functional MRI was per-
formed using a single-shot gradient-echo echo-planar im-
aging sequence (relaxation time, 2500 milliseconds; echo
time, 60 milliseconds; 16 axial slices, resolution 3 	 3 	 8
mm; 10 seconds dummy scans).
Data processing. Data were processed on an SGI work-
station (Silicon Graphics, Inc., Mountain View, CA) using
the Statistical Parametric Mapping package (SPM99b).
The first processing step was motion correction.23 Only
data sets with less than 0.8 mm maximal displacement
and less than 1° rotation during an entire scan were used.
Two of the patients with HIV and one control subject had
Figure 1. Schematic diagrams show the sequential letter
tasks and the sequential number tasks.
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excess motion and their data were discarded. However,
three additional subjects fulfilling the same criteria were
recruited for the study; therefore, all 22 subjects included
in the data analyses fulfilled these criteria. Next, the echo-
planar images were coregistered to the high-resolution
scans24 and transformed into Talairach space, using a full
affine transformation and 4 	 5 	 4 spatial cosine trans-
formations and spatial smoothing with a 10-mm Gaussian
filter.
Activation maps were calculated for each paradigm and
group using the general linear model with fixed-effect
analysis.25 The design matrix was generated with a
6-second delayed boxcar reference function, a high-pass
filter (cutoff, 1/120 Hz), and intersubject scaling. The re-
sulting activation maps reflect the probability (t-score) of a
region to be activated (increased BOLD signal intensity)
during the task (minimum threshold T  3.1, or p  0.001;
cluster size 40).
In addition, SPM difference maps comparing BOLD sig-
nal differences between patients with HIV and control sub-
jects were calculated (also with T  3.1; cluster size 40).
To evaluate for possible relationships between the BOLD
signal changes and task performance, we performed linear
regression analyses, separately for the posterior parietal
cortex (PPC) and lateral prefrontal cortex (LPFC), using
the individual percentage signal change values as indepen-
dent variable and the individual reaction times and perfor-
mance as dependent variables.
Results. Patients clinical characteristics. The patients
with HIV had the following clinical characteristics: CD4
cell count, 329  197/mL; nadir CD4 cell count, 170 
126/mL; plasma viral load, 30,959  36,549 copies/mL;
Karnofsky score, 88  9 (normal function, 100); HIV de-
mentia scale score, 13.0  3.4 (maximum, 16); and AIDS
dementia complex (ADC) stage, 0.5  0.1. Four patients
with HIV had minor cognitive motor disorder (ADC stage
0.5); three had mild HIV dementia (ADC stage 1); and four
were asymptomatic for cognitive deficits (ADC stage 0). All
except one patient with HIV were taking antiretroviral
medications. Two patients were taking two antiretroviral
medications (didanosine [ddI] and stavudine [d4T]; d4T
and lamivudine [3TC]); four patients were taking three
antiretroviral medications (3TC, zidovudine [AZT], and
indinavir [IDV]; IDV, 3TC, and d4T; IDV, AZT, and 3TC;
d4T, nelfinavir [NFV], and nevirapine [NVP]); one patient
was taking four antiretroviral medications (ritonavir
[RIT], saquinavir [SQV], d4T, and 3TC); and three patients
were taking five antiretroviral medications (ddI, RIT, IDV,
Figure 2. Group activation data for the
one-increment task in patients with
HIV (top row) and seronegative control
subjects (middle row). Note the signifi-
cantly greater activation in some brain
regions of the patients with HIV com-
pared with the control subjects (bottom
row). The color scale indicates T-scores;
only activated areas with a threshold
(T  3.1, p  0.001) are displayed on
the surface views. LPFC  lateral pre-
frontal cortex; PPC  posterior parietal
cortex; SMA  supplementary motor
area.
Figure 3. Group activation data for the
one-increment task in patients with
HIV and seronegative control subjects
showed in the cross-sectional views
(sagittal, axial, and coronal). Note acti-
vation in the caudate brain regions bi-
laterally in the control subjects (right)
but that greater activation is observed
in the head of the caudate (arrows) and
the subcortical frontal regions of the
patients with HIV (left). The color scale
indicates T-scores; only activated areas
with a threshold T  3.1, p  0.001,
are shown.
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d4T, and SQV; 3TC, IDV, NVP, 3TC, and NVP; NFV, NVP,
RIT, abacavir, and d4T). No cerebral atrophy or brain le-
sions were observed in any of the subjects.
fMRI results. All participants showed similar patterns
of activation with each task. With the simple reaction task
and the four working memory tasks, all participants
showed activation consistently in the LPFC (Talairach co-
ordinates, 45, 0, 45), PPC (30, 
70, 55), and caudate
(7, 
15, 20) bilaterally. In addition, the supplementary
motor area (SMA) (0, 0, 65) was activated consistently for
the working memory tasks; however, at the threshold of
3.1, the SMA is visible on the group data only for the
two-back task in the patients with HIV more than the
control subjects, and on the sequential number tasks only
in the patients with HIV. The brain regions activated dur-
ing the one-increment task were mapped on the brain sur-
face (figure 2) and on cross-sections through the caudate
(figure 3). Compared with the control subjects, patients
with HIV showed significantly greater BOLD activation
predominantly in the frontal regions, inferior LPFC, and
the SMA (see figure 2, arrows).
Patients with HIV showed greater brain activation
(BOLD signal changes) in some brain regions compared
with the control subjects for each tasks (figure 4). Regional
comparisons show that compared with control subjects, pa-
tients with HIV activate significantly more in the left and
middle parietal regions for the simple reaction and the
one-back tasks (see figure 4, right columns), but signifi-
cantly more in the frontal regions (LPFC and SMA) for the
more difficult tasks, sequential numbers, and two-back
tasks (see figure 4, right columns). These regions with
greater activation in the patients with HIV were typically
in the periphery of, or adjacent to, the corresponding re-
gions activated in the control subjects. In contrast, brain
regions activated in the control subjects typically also were
activated in the patients with HIV; there were no differ-
ences in the BOLD signals in the regions that were acti-
vated in both groups (see figure 2).
Performance during fMRI. All participants performed
more slowly and less accurately as the tasks required in-
creasing load on working memory and attention (table).
The increasing order of task difficulty was confirmed by
the increasing reaction times on these tasks (analysis of
variance, p  0.0001); post hoc analyses showed significant
differences in reaction times between all the tasks (rang-
ing from p  0.006 to p  0.0001), except for those between
one-increment and one-back, which had similar reaction
times. Compared with the control subjects, the patients
with HIV showed no significant difference in accuracy, but
were slower in performing these tasks (analysis of vari-
ance, p  0.05; see the table). The patients’ reaction time
was slowest (
23%) and least accurate (
11%) for the
most difficult task in the table (two-increment). In the
patients with HIV, but not in the control subjects,
the percentage of signal change in most of the activated
brain regions correlated with the performance on the se-
quential number tasks (positively with reaction times and
negatively with percentage of accuracy), but not on the
simple reaction time or one-back task because almost all
subjects performed at 100% (see the table).
Figure 4. Glass brain views of Statistical Parametric Mapping package (SPM99b) maps of brain activation in control
subjects (left column) and patients with HIV (middle column), and the difference maps (patients with HIV  control sub-
jects) for simple reaction task and sequential letter tasks. The left and middle columns represent significant differences
between activated state and resting state. The right column represents significantly greater activation (BOLD signal
change) in patients with HIV compared with that in the control subjects. All maps are shown at the same threshold
T-score of 3.1 (p  0.001, cluster size 40, representing pixels consistently activated across all subjects). For the simpler
tasks (simple reaction and one-back), patients with HIV showed greater activation in the parietal regions. However, with
more difficult tasks, patients with HIV showed greater activation additionally in the frontal lobes.
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Discussion. This preliminary study compares
brain activation in patients with HIV with that in
control subjects. The two groups were carefully
matched for age, education, handedness, and sex,
because each of these variables might cause differ-
ences in the pattern and extent of brain activation.26
The fMRI activation paradigms used in this study
produced robust and consistent activation of the
LPFC, the PPC, and the SMA across participants, as
observed in previous studies of working memory.27-31
We also observed caudate activation associated with
the working memory tasks.26 In the control subjects
and the patients with HIV, brain activation in-
creased with task difficulty, from simple reaction to
sequential letters or numbers. Similar results of in-
creased brain activation with increased task diffi-
culty have been reported.26,32,33 These findings imply
a relationship between the cognitive load and the
signal changes on fMRI, probably because of task-
related attentional modulation of neuronal activity
or, alternatively, recruitment of the neuronal reserve
capacity to solve the more complicated tasks. For
this discussion, we define attentional modulation as
the influence of attention on brain function, as mea-
sured by the changes on fMRI signals, and neuronal
reserve capacity is defined as the additional capacity
of a neural network to perform a certain function.
The patients with HIV showed greater activation
(BOLD signal changes) in some brain regions com-
pared with control subjects while performing each of
these tasks. The greater activation in the patients
with HIV often occurred in the periphery of or adja-
cent to the corresponding activated brain regions in
the control subjects, but typically not in the regions
already activated in the control subjects. This out-
ward extension of the brain activation pattern sug-
gests a saturation of the neural activity in the
normally activated regions and a need to recruit ad-
jacent neural substrate, and it supports the hypothe-
sis that the reserve system of the neuronal network
is being used.
Injury to the neural substrate attributable to the
HIV infection appears to necessitate greater atten-
tional modulation of the neural circuits, hence a
greater use of the neuronal reserve, to maintain perfor-
mance on the simpler tasks (simple reaction and one-
back), with little or minimal reserve left for the more
complex tasks. This hypothesis is partly supported by
the trend that on the simple reaction task, patients
with HIV were able to maintain their performance ac-
curacy (
2%) despite being 16% slower compared with
the seronegative control subjects. The slower perfor-
mance may reflect increased time required for addi-
tional neural processing. However, the patients were
23% slower on the most difficult task (two-increment)
and were least accurate (
11%) (see the table). There-
fore, with the more difficult tasks, if little or no brain
reserve is left, performance might not be maintained.
Table Performance data (reaction times and % accuracy), p values, and correlations with % signal changes in LPFC and PPC
Reaction
Seronegative
control subjects
Patients
with HIV
%
Differences p Value
Correlation with % signal
change in LPFC in
patients with HIV
Correlation with % signal
change in PPC in
patients with HIV
Left Right Left Right
Simple reaction
Time, ms 331  47 384  117 16% NS NS NS NS NS
% Accuracy 99.9  0.4 98  2.8 
2% NS NS NS NS NS
1-Back
Time, ms 471  49 548  82 16% 0.03 NS NS NS NS
% Accuracy 99.5  1.6 96  6 
3.5% NS NS NS NS NS
1-Increment
Time, ms 491  53 593  119 21% 0.03 r  0.65 r  0.76 r  0.60 NS
p  0.02 p  0.003 p  0.03
% Accuracy 83  9.6 84  7 
1% NS NS r  
0.74 NS NS
p  0.004
2-Increment
Time, ms 573  136 703  217 23% 0.08 r  0.64 NS r  0.62 r  0.56
p  0.02 p  0.02 p  0.05
% Accuracy 73  12 65  18 
11% NS r  
0.49 r  
0.66 r  
0.64 r  
0.56
NS p  0.01 p  0.02 p  0.05
Because of technical errors, data for 2-back were lost.
p Values of 0.05 are considered significant.
NS  not significant; LPFC  lateral prefrontal cortex; PPC  posterior parietal cortex.
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Furthermore, the BOLD signal change in the LPFC
correlated with the performance (reaction time and ac-
curacy) on the sequential number tasks. Patients with
HIV and higher BOLD signal changes were slower and
less accurate. Together, these findings indicate that the
neural substrate for cognitive deficits in patients with
HIV-associated brain injury is increased requirement
for attentional modulation.
The regional difference in brain activation be-
tween the patients with HIV and the control subjects
provides further insight into the processes underly-
ing the cognitive deficits. With the simpler tasks
(simple reaction and one-back), the PPC were acti-
vated more in the patients with HIV than in the
control subjects. In contrast, the more complex tasks
(two-back, one-up, and two-up) caused relatively
more activation in the frontal brain regions (LPFC
and SMA) of the patients with HIV. The SMA, in
particular, is observable in the group data for one-up
and two-up tasks only in the patients with HIV, but
not in the control subjects, and more in the two-back
task in the patients with HIV than in the control
subjects. These findings suggest a shift of neural
processing with increased cognitive load from the
parietal to the frontal brain regions in the patients
with HIV compared with the control subjects. Two
factors may contribute to this regional shift in atten-
tional modulation with task difficulty.
First, attention-requiring tasks are associated
with greater activation in the frontal cortices than
the parietal cortices, even in healthy subjects. This
has been shown in an fMRI study of visual attention
in healthy subjects, in which moderate attentional
modulation (moderate increase of the fMRI signal)
was observed in the PPC, but strong modulation
(larger increase of fMRI signal) was found in the
LPFC and SMA.34 Second, injury in the frontostriatal
system may necessitate even greater attentional
modulation, with recruitment of additional neural
processes and greater frontal activation in the pa-
tients with HIV than in the control subjects, to per-
form these working memory tasks. The frontostriatal
system is often most severely affected in patients
with HIV dementia based on neuropathologic and
neuroimaging studies.16,35-37 In particular, the dopa-
minergic system, which has a major role in regulat-
ing working memory function in the prefrontal
cortices,38 may be affected in HIV dementia.39,40
Working memory deficits have been reported and
observed in patients with HIV dementia,9-11 but pa-
tients with HIV who were asymptomatic were found
to have normal working memory.12 Although the ac-
curacy on the working memory tasks in our patients
with HIV was not different from that in the control
subjects, increased task-dependent brain activation,
especially in the frontal lobes, was observed in the
patients with HIV. Therefore, fMRI may be more
sensitive than clinical evaluations for detecting
working memory deficits associated with HIV brain
injury.
Increases in brain activation in selected brain re-
gions also have been reported in other brain disor-
ders, including children with attention deficit
disorder,41 adults with mild traumatic brain injury42
or schizophrenia,43 and people at risk for AD.44
Therefore, the concept that brain injury leads to in-
creased use of brain reserve capacity may be further
supported from fMRI studies of other brain
disorders.
One potential confound in the current study is
that all patients but one were taking antiretroviral
medications. The BOLD fMRI signal may be affected
by medications, as has been observed in schizo-
phrenic patients who were taking typical antipsy-
chotic medications.45 Unlike typical antipsychotic
medications that affect the dopaminergic system
and, therefore, indirectly affect the microvascula-
ture, antiretroviral medications are not known to af-
fect cerebral perfusion. Previous studies in patients
with HIV, however, have shown alterations in cere-
bral perfusion,15,46 which also may contribute to the
abnormal BOLD signals. The relationship between
altered cerebral perfusion and BOLD signal changes
is unknown. However, the current study showed
task-dependent activation changes in patients with
HIV that are difficult to explain based solely on vas-
cular abnormalities. Nevertheless, future fMRI stud-
ies should evaluate perfusion and BOLD signal
changes in the same patients with HIV before and
during antiretroviral treatment to understand the
relationship between perfusion abnormalities and
BOLD signal changes and to exclude the possibility
that these medications might affect cerebral perfu-
sion or the BOLD signal.
The task-dependent increased frontal activation in
the patients with HIV suggests that the neural cor-
relate of attentional deficits may be excessive atten-
tional modulation as a result of frontostriatal brain
injury. The presence of abnormalities in the fMRI
response in the patients with HIV, even with the
simpler tasks, indicates that fMRI is exquisitely sen-
sitive for detecting injury to the neural substrate in
patients with HIV. Future studies will determine
whether these fMRI techniques can be used to moni-
tor the efficacy of antiretroviral medications.
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